Abstract
Genetic Engineering & Biotechnology NewsVol. 43, No. 6 BioprocessingProspects for the Oral Delivery of BiopharmaceuticalsThe demand for orally administered biologics may be met through the development of permeation enhancers, lipid-based nanocarriers, and ingestible injectable devicesGareth John MacdonaldGareth John MacdonaldSearch for more papers by this authorPublished Online:5 Jun 2023https://doi.org/10.1089/gen.43.06.16AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetails Volume 43Issue 6Jun 2023 Information© 2023 by GEN PublishingTo cite this article:Gareth John Macdonald.Prospects for the Oral Delivery of Biopharmaceuticals.Genetic Engineering & Biotechnology News.Jun 2023.44-46.http://doi.org/10.1089/gen.43.06.16Published in Volume: 43 Issue 6: June 5, 2023PDF download
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
